Efficient simultaneous tumor targeting delivery of all-trans retinoid acid and paclitaxel based on hyaluronic acid-based multifunctional nanocarrier

Molecular Pharmaceutics

Volumn 10, Issue 3, 2013, Pages 1080-1091

  Yao, Jing ^a   Zhang, Li ^a,b   Zhou, Jianping ^a   Liu, Hongpan ^a   Zhang, Qiang ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Department of Pharmacy   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

all trans retinoid acid; codelivery; combination chemotherapy; hyaluronic acid; tumor targeting

Indexed keywords

DOXORUBICIN; HYALURONIC ACID; NANOCARRIER; NANOPARTICLE; PACLITAXEL; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ERYTHROCYTE; FEMALE; HEMOLYSIS; MELANOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RABBIT; TUMOR XENOGRAFT;

EID: 84874618208     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3005808     Document Type: Article

References (42)

1. Rowinsky, E. K.; Donehover, R. C. Paclitaxel (Taxol) New Engl. J. Med. 1995, 332, 1004-1014
2. Fader, A. N.; Nagel, C.; Axtell, A. E.; Zanotti, K. M.; Kelley, J. L.; Moore, K. N.; Secord, A. A.; Walsh, C. S.; Huh, W. K.; Gehrig, P. A.; Gibbons, H.; Rose, P. G.; Havrilesky, L. J.; Tuller, E.; Drake, R. D.; Bottsford-Miller, J.; O'Malley, D. M. UPSC Consortium. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes Gynecol. Oncol. 2009, 112, 558-562
3. Kato, J.; Nagahara, A.; Iijima, K.; Kodani, T.; Higashihara, Y.; Yoshimura, M.; Serizawa, N.; Osada, T.; Yoshizawa, T.; Otaka, M.; Watanabe, S. Phase I study of paclitaxel, cisplatin and 5-fluorouracil combination chemotherapy for unresectable/recurrent gastric cancer Adv. Med. Sci. 2010, 55, 137-142
4. Sun, J.; Huang, H.; Zhu, Y.; Lan, J.; Li, J.; Lai, X.; Yu, J. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells Int. J. Hematol. 2005, 82, 215-223
5. Pratt, M. A.; Niu, M. Y.; Renart, L. I. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells Apoptosis 2006, 11, 589-605
6. Karmakar, S.; Banik, N. L.; Ray, S. K. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice Cancer 2008, 112, 596-607
7. Hong, G. Y.; Jeong, Y. I.; Lee, S. J.; Lee, E.; Oh, J. S.; Lee, H. C. Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma Arch. Pharm. Res. 2011, 34, 407-417
8. Park, K. M.; Kang, H. C.; Cho, J. K.; Chung, I. J.; Cho, S. H.; Bae, Y. H.; Na, K. All-trans-retinoic acid (ATRA)-grafted polymeric gene carriers for nuclear translocation and cell growth control Biomaterials 2009, 30, 2642-2652
9. Bae, Y.; Diezi, T. A.; Zhao, A.; Kwon, G. S. Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents J. Controlled Release 2007, 122, 324-330
10. Garnett, M. C. Targeted drug conjugates: principles and progress Adv. Drug Delivery Rev. 2001, 53, 171-216
11. Hou, L.; Fan, Y.; Yao, J.; Zhou, J.; Li, C.; Fang, Z.; Zhang, Q. Low molecular weight heparin-all-trans-retinoid acid conjugate as a drug carrier for combination cancer chemotherapy of paclitaxel and all-trans-retinoid acid Carbohydr. Polym. 2011, 86, 1157-1166
12. Verschraegen, C. F.; Skubitz, K.; Daud, A.; Kudelka, A. P.; Rabinowitz, I.; Allievi, C.; Eisenfeld, A.; Singer, J. W. Oldham, F.B. A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors Cancer Chemother. Pharmacol. 2009, 63, 903-910
13. Lammers, T.; Subr, V.; Ulbrich, K.; Peschke, P.; Huber, P. E.; Hennink, W. E.; Storm, G. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 2009, 30, 3466-3475
14. Shan, L.; Xue, J.; Guo, J.; Qian, Z.; Achilefu, S.; Gu, Y. Improved targeting of ligand-modified adenovirus as a new near infrared fluorescence tumor imaging probe Bioconjugate Chem. 2011, 22, 567-581
15. Yao, J.; Fan, Y.; Du, R.; Zhou, J.; Lu, Y.; Wang, W.; Ren, J.; Sun, X. Amphoteric hyaluronic acid derivative for targeting gene delivery Biomaterials 2010, 31, 9357-9365
16. Ito, T.; Iida-Tanaka, N.; Koyama, Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid J. Drug Target. 2008, 16, 276-281
17. Platt, V. M.; Szoka, F. Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan Receptor Mol. Pharmaceutics 2008, 5, 474-486
18. Jiang, G.; Park, K.; Kim, J.; Kim, K. S.; Oh, E. J.; Kang, H.; Kang, H.; Han, S. E.; Oh, Y. K.; Park, T. G.; Hahn, S. K. Hyaluronic acid -polyethyleneimine conjugate for target specific intracellular delivery of siRNA Biopolymers 2008, 89, 635-641
19. Auzenne, E.; Ghosh, S. C.; Khodadadian, M.; Rivera, B.; Farquhar, D.; Price, R. E.; Ravoori, M.; Kundra, V.; Freedman, R. S.; Klostergaard, J. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts Neoplasia 2007, 9, 479-486
20. Luo, Y.; Ziebell, M. R.; Prestwich, G. D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells Biomacromolecules 2000, 1, 208-218
21. Zhang, Y.; Huo, M.; Zhou, J.; Yu, D.; Wu, Y. Potential of amphiphilically modified low molecular weight chitosan as a novel carrier for hydrophobic anticancer drug: Synthesis, characterization, micellization and cytotoxicity evaluation Carbohydr. Polym. 2009, 77, 231-238
22. Zhu, J.; Liao, L.; Bian, X.; Kong, J.; Yang, P.; Liu, B. pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres Small 2012, 8, 2715-2720
23. Wang, X.; Li, J.; Wang, Y.; Cho, K. J.; Kim, G.; Gjyrezi, A.; Koenig, L.; Giannakakou, P.; Shin, H. J.; Tighiouart, M.; Nie, S.; Chen, Z. G.; Shin, D. M. HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors ACS Nano 2009, 3, 3165-3174
24. Min, K. H.; Park, K.; Kim, Y. S.; Bae, S. M.; Lee, S.; Jo, H. G.; Park, R. W.; Kim, I. S.; Jeong, S. Y.; Kim, K.; Kwon, I. C. Hydrophobically modified glycol chitosan nanoparticales-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy J. Controlled Release 2008, 127, 208-218
25. Park, K.; Lee, G. Y.; Kim, Y. S.; Yu, M.; Park, R. W.; Kim, I. S.; Kim, S. Y.; Byun, Y. Heparin-deoxycholic acid chemical conjugate as an antitumor drug carrier and its antitumor activity J. Controlled Release 2006, 114, 300-306
26. Han, S.; Liu, Y.; Nie, X.; Xu, Q.; Jiao, F.; Li, W.; Zhao, Y.; Wu, Y.; Chen, C. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles Small 2012, 8, 1596-1606
27. Yue, J.; Liu, S.; Wang, R.; Hu, X.; Xie, Z.; Huang, Y.; Jing, X. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models Mol. Pharmaceutics 2012, 9, 1919-1931
28. Dong, Y.; Feng, S. S. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy Biomaterial 2007, 28, 4154-4160
29. Jung, B.; Jeong, Y. C.; Min, J. H.; Kim, J. E.; Song, Y. J.; Park, J. K.; Park, J. H.; Kim, J. D. Tumor-binding prodrug micelles of polymer-drug conjugates for anticancer therapy in HeLa cells J. Mater. Chem. 2012, 22, 9385-9394
30. AshaRani, P. V.; Mun, G. L. K.; Hande, M. P.; Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells ACS Nano 2009, 3, 279-290
31. Mangiarotti, R.; Danova, M.; Alberici, R.; Pellicciari, C. All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells Br. J. Cancer 1998, 77, 186-191
32. Jia, P.; Chen, G.; Huang, X.; Cai, X.; Yang, J.; Wang, L.; Zhou, Y.; Shen, Y.; Zhou, L.; Yu, Y.; Chen, S.; Zhang, X.; Wang, Z. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3 Chin. Med. J. (Engl). 2001, 114, 19-24
33. Lotan, R. Retinoids and Apoptosis: Implications for cancer chemoprevention and therapy J. Natl. Cancer Inst. 1995, 87, 1655-1657
34. Nehmé, A.; Varadarajan, P.; Sellakumar, G.; Gerhold, M.; Niedner, H.; Zhang, Q.; Lin, X.; Christen, R. D. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells Br. J. Cancer. 2001, 84, 1571-1576
35. Wang, H.; Zhao, Y.; Wu, Y.; Hu, Y.; Nan, K.; Nie, G.; Chen, H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles Biomaterial 2011, 32, 8281-8290
36. Sessler, R. J.; Noy, N. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II Mol. Cell 2005, 18, 343-353
37. Bastien, J.; Rochette-Egly, C. Nuclear retinoid receptors and the transcription of retinoid-target genes Gene 2004, 328, 1-16
38. Upadhyay, K. K.; Bhatt, A. N.; Mishra, A. K.; Dwarakanath, B. S.; Jain, S.; Schatz, C.; Meins, J. F.; Farooque, A.; Chandraiah, G.; Jain, A. K.; Misra, A.; Lecommandoux, S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl L-glutamate)-b-hyaluronan polymersomes Biomaterials 2010, 31, 2882-2892
39. Yang, C.; Tan, J. P. K.; Cheng, W.; Attia, A. B. E.; Ting, C. T. Y.; Nelson, A.; Hedrick, J. L.; Yang, Y. Y. Supramolecular nanostructures designed for high cargo loading capacity and kinetic stablility Nanotechnol. Today 2010, 5, 515-523
40. Kohane, D. S. Microparticles and nanoparticles for drug delivery Biotechnol. Bioeng. 2007, 96, 203-209
41. Tan, B.; Wang, J. H.; Wu, Q. D.; Kirwan, W. O.; Redmond, H. P. Sodium hyaluronate enhances colorectal tumor cell metastatic potential in vitro and in vivo Br. J. Surg. 2001, 88, 246-250
42. Yin, D.; Ge, Z.; Yang, W.; Liu, C.; Yuan, Y. Inhibition of tumor metastasis in vivo by combination of paclitaxel and hyaluronic acid Cancer Lett. 2006, 243, 71-79